Radiation safety in the central radiopharmacy

https://doi.org/10.1016/S0001-2998(96)80032-8Get rights and content

The currently increasing number of new radiopharmaceuticals and the increase in individual patient-dose activity, particularly for single photon emission computer tomography imaging, coupled with the switch toward unit doses probably contribute to an increase in the radiation burden to radiopharmacy personnel. To meet this increased need of the nuclear medicine community, a medium-sized radiopharmacy may order seven to eight 3-Ci molybdenum-99/technetium-99M generators per week and may perform 10 to 15 elutions per day. The maximum radiation exposure to radiopharmacy personnel occurs during the generator elutions, compounding (kit preparation), and unitdose dispensing. Additional sources of radiation exposure can occur during receipt of radioactive packages, transport of prepared doses, and the process of storage and disposal of radioactive waste. Recent reports have shown extremity radiation doses to the fingers and hands at 14 to 21 rem/year. Radiation exposure can be monitored by film badges, thermoluminescent detectors, or one of the analog or digital self-reading dosimeters. Each monitoring device has advantages and the choice depends upon the personnel involved (eg, visitors) and the particular needs of the radiopharmacy. Extremity dose reductions during radiopharmacy procedures can be achieved by a number of techniques, some as simple as the use of 8- to 9-inch forceps during transfers of radioactive vials and syringes and the use of a dose-drawing syringe shield during unit-dose dispensing procedures. In preparation of unsealed doses or capsules of radioactive iodine, there is a potential for a high internal dose because of inhalation of the volitile solution. Frequent monitoring in the form of bioassays and the use of strict threshold levels will ensure early detection of exposure to radioactive iodine and quick corrective action. In pharmacies and nuclear medicine departments handling fluorine-18 for use with Anger gamma cameras, the high levels of both beta and gamma radiation present an additional set of radiation safety problems.

References (15)

  • MurphyPH

    Guidelines for radiation protection

    Semin Nucl Med

    (1986)
  • National Archives and Records Administration

    Code of Federal Regulations, title 10

    Federal Register

    (1995)
  • United States Nuclear Regulatory Commission

    Information relevant to ensuring that occupational radiation exposures at medical institutions will be as low as reasonably achievable

    (1982)
  • DePueyEG et al.

    Fast stress and rest acquisitions for technetium-99m-sestamibi separate-day SPECT

    J Nucl Med

    (1995)
  • CulverMC et al.

    Comparison of personnel radiation dosimetry from myocardial perfusion scintigraphy: Technetium-99m-sestamibi versus thallium-201

    J Nucl Med

    (1993)
  • OwensTP et al.

    The effect of job duties in contributing to radiation exposure of the nuclear medicine technologist

    J Nucl Med Technol

    (1995)
  • United States Nuclear Regulatory Commission

    Guide for the preparation of applications for medical use programs. Part G

    (1987)
There are more references available in the full text version of this article.

Cited by (7)

  • Internal dosimetry of nuclear medicine workers through the analysis of <sup>131</sup>I in aerosols

    2015, Applied Radiation and Isotopes
    Citation Excerpt :

    The handling of solutions containing radioiodine can result in a significant risk of occupational exposure due to the possibility of incorporation via inhalation or ingestion (IAEA, 1999; Schwartz et al., 1991). Several studies have been published about occupational exposure in nuclear medicine procedures, where increased use of radioisotopes and availability of suitable methodologies for individual dose assessment have been discussed (Baechler et al., 2011; Bento et al., 2012; Dantas et al., 2007; Dumeau et al., 2011; Heller, 1996; Jansen et al., 1994; Kletter et al., 1999; Vidal et al., 2007). A previous study including in vivo and in vitro methods performed by Lucena et al. (2007), showed the occurrence of 131I incorporation by workers involved in handling of solutions used for radioiodine therapy.

  • Radiopharmaceuticals for therapy

    2016, Radiopharmaceuticals for Therapy
  • IARC Monographs Programme on the Evaluation of Carcinogenic Risks to Humans

    2001, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
View all citing articles on Scopus
View full text